Resilience and vulnerabilities of tumor cells under purine shortage stress
Jianpeng Yu(Duke University), Jiaoti Huang(Space Science Institute), Daniel J. George(Duke University), David M. Ashley(Unknown), Michael A. Sun(Duke Medical Center), Nomingerel Tserentsoodol(Duke University), Michelle Bowie(Creative Research Enterprises (United States)), Xue Jiang(Zhejiang Chinese Medical University), Fan Zhang(Southwest Medical University), Hong Zhang(Central South University), Yiping He(Dalian University of Technology), Xia Gao(Nanjing Drum Tower Hospital), Jin Chen(Duke University), David H. Moon(Duke University), Christopher J. Pirozzi(Duke University), Robert Wild, Cheng Su(Duke University)
Cited by 1
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618